(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
. . . . . . . . . .



Webinar on Artificial Intelligence (AI) in Vaccine Research & Development [1]

[]

Date: 2024-11-21

Artificial intelligence (AI) can now simulate human reasoning, learn from new information and make predictions. The value of AI was recently demonstrated in the COVID-19 pandemic, whereby AI-based approaches were used to accelerate mRNA vaccine antigen design and the conduct clinical trials, helping developers to go from a viral sequence to approved product in less than one year. But we are still in early days. In addition to machine and deep-learning, generative AI will transform vaccine development faster than we ever imagined.

In this webinar we will explore

What is AI? The history and applications of AI How to collect and format data for global use

AI approaches in Vaccine Discovery Antigen and epitope discovery Rational vaccine design

AI approaches in Vaccine Development Product optimization / manufacturing Clinical design and execution Regulatory considerations



Expert panel discussions will focus on lessons learned, challenges, risks and opportunities using AI to accelerate vaccine development against global threats.

[END]
---
[1] Url: https://www.who.int/news-room/events/detail/2024/11/21/default-calendar/webinar-on-artificial-intelligence-(ai)-in-vaccine-research---development

Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.

via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/

You are viewing proxied material from magical.fish. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.